FAKTOR OPTIONSSCHEIN - ELI LILLY & CO | Market Closed - Deutsche Boerse AG 01:20:28 04/07/2024 am IST | ||
| 0.189 EUR | +2.72% |
|
| 1 month | -19.57% | ||
| 3 months | -37.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 0.189 | +2.72% |
| 02/24/02 | 0.184 | +2.22% |
| 01/24/01 | 0.18 | -2.17% |
| 28/24/28 | 0.184 | -0.54% |
| 27/24/27 | 0.185 | -2.12% |
Delayed Quote Deutsche Boerse AG
Last update July 04, 2024 at 01:20 am IST
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PE3SLY |
| ISIN | DE000PE3SLY9 |
| Date issued | 02/06/2022 |
| Strike | 905.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.85 € |
|---|---|
| Lowest since issue | 0.179 € |
| Spread | 0.004 € |
| Spread % | 2.07% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
898.1
USD
Average target price
870.3
USD
Spread / Average Target
-3.10%
- Stock Market
- Certificates
- Certificat
